EP3201203
CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOLE-3-CARBOXAMIDE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.9.2015EP published:
19.5.2021EP application number:
15778162.6
EPO information:
European Patent Register
Max expiry date:
28.9.2035
Title:
CRYSTALLINE FORM OF 1-(1-METHYL-1H-PYRAZOL-4-YL)-N-((1R,5S,7S)-9-METHYL-3-OXA-9-AZABICYCLO[3.3.1]NONAN-7-YL)-1H-INDOLE-3-CARBOXAMIDE
Timeline
Today
29.9.2015EP application
19.5.2021EP Publication
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
Inventor
Name:
ZHAO, YuxinAddress:
San Diego, California 92121, US
Priority
Number:
201462056982 PDate:
29.9.2014Country:
US
Classification
Categories:
C07D 498/08, A61K 31/5386, A61P 1/00, A61P 1/08, A61P 25/06, A61P 25/16, A61P 25/18, A61P 25/22, A61P 25/24, A61P 25/30